• Home
  • About Us
    • Who Are We ?

    • Vision & Mission

    • Promoters
  • Manufacturing Sites
    • BLL (WHO-GMP) ------

    • Brooks Steriscience
  • Our Products
    • General Products   
      • Liquid Injection Ampoules

      • Liquid Injection Vials

      • Dry Powder Injection Vials

      • Lyophilized Injections

      • Eye/Ear Drops

      • Nasal Drops

    • β-Lactam Range  
      • Tablets

      • Dry Powder Syrup

      • Injection

    • Cephalosporin Range  
      • Tablets

      • Dry Powder Syrup

      • Injection
  • Sales & Marketing
    • India  
      • CCD

      • Institutional Business

      • CDMO Services

    • International  
      • Our Global Presence
  • Investors
    • Investors Forum

    • Committee Details
  • Contact Us
    • Product Enquiry

    • Investor Enquiry

    • Career Enquiry

Annual Reports Of Subsidiary Companies

Details of Business Disclaimer Financial Results Annual Report Annual Return MOA AOA Preferential Allotment List of Directors Shareholding Pattern Newspaper Advertisements Policies Notices Voting Results Disclosure Under Regulation-30 Secreterial Compliance Report Annual Reports of Subsidiary Companies Related Party Transaction Investors Contact Investor Forms Right Issue Prospectus Credit Rating

Annual Reports Of Subsidiary Companies

  • Brooks Steriscience Limited 4th Annual Report 2023-2024
  • Brooks Steriscience Limited 3rd Annual Report 2022-2023
  • Brooks Steriscience Limited 2nd Annual Report 2021-2022
  • Brooks Steriscience Limited 1st Annual Report 2020-2021
  • BSE Code - 533543
  • NSE Symbol - BROOKS
  • With roots dating back to 2002, Brooks Laboratories were established with a sole purpose of being a pioneer in the Pharmaceutical industry.
News & Articles
  • Events
Useful Links
  • Policy
  • Annual Reports
  • BLL(WHO-GMP)
  • Brooks Steriscience
Reach Us

Copyright © 2025 Brooks Laboratories. All right reserved. Designed by Sharptech Company